Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

Arzu Didem Yalcin; Atil Bisgin; Aysegul Kargi; Burhan Savas; Metin Erkilic; Antonia Dimitrakopoulou-Strauss; Ludwig Strauss

首页> 外文期刊>World Allergy Organization Journal >Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

【24h】

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

机译：基础和临床免疫学–3031。贝伐单抗治疗的结肠癌中sTRAIL和CXCL8的血清学模式与FDG-PET / CT结果之间的相关性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《World Allergy Organization Journal》 |2013年第1期|共页
作者
Arzu Didem Yalcin; Atil Bisgin; Aysegul Kargi; Burhan Savas; Metin Erkilic; Antonia Dimitrakopoulou-Strauss; Ludwig Strauss;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类变态反应性疾病;
关键词

相似文献

外文文献
中文文献

1. Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer [J] . Atil Bisgin, Aysegul Kargi, Arzu D Yalcin, BMC Cancer . 2012,第1期

机译：血清sTRAIL水平升高与贝伐单抗治疗的转移性结肠癌的生存率相关
2. Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer [J] . Atil Bisgin, Aysegul Kargi, Arzu D Yalcin, BMC Cancer . 2012,第1期

机译：血清sTRAIL水平升高与贝伐单抗治疗的转移性结肠癌的生存率相关
3. Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-Bevacizumab or FOLFIRI-bevacizumab: Results from ARIES, a bevacizumab observational cohort study [J] . BendellJ.C., Bekaii-SaabT.S., CohnA.L., The oncologist . 2012,第12期

机译：最初用FOLFOX-贝伐单抗或FOLFIRI-贝伐单抗治疗的转移性结直肠癌患者的治疗模式和临床结局：贝伐单抗观察性队列研究ARIES的结果
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers [O] . Arzu Didem Yalcin, Atil Bisgin, Aysegul Kargi, 2013

机译：基础和临床免疫学–3031。贝伐单抗治疗的结肠癌中sTRAIL和CXCL8的血清学模式与FDG-PET / CT结果之间的相关性
6. Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers [O] . 2013

机译：基础和临床免疫学–3031。贝伐单抗治疗的结肠癌中sTRAIL和CXCL8的血清学模式与FDG-PET / CT结果之间的相关性

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

著录项

相似文献

相关主题

期刊订阅